Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa.
about
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysisContraceptive methods and risk of HIV acquisition or female-to-male transmissionHormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studiesInjectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk?The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.Are hormonal contraceptive users more likely to misreport unprotected sex? Evidence from a biomarker validation study in Zimbabwe.Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraceptionRisk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.From 'sugar daddies' to 'sugar babies': exploring a pathway among age-disparate sexual relationships, condom use and adolescent pregnancy in South Africa.Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.Prevalence of Herpes Simplex Virus 2 (HSV-2) infection and associated risk factors in a cohort of HIV negative women in Durban, South Africa.An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African WomenAn updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis.Contraceptive options for HIV-positive women: making evidence-based, patient-centred decisions.Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.Assessing the Potential Impact of Hormonal-Based Contraceptives on HIV Transmission Dynamics Among Heterosexuals.Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract.Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?Application of causal inference methods in the analyses of randomised controlled trials: a systematic review.Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.Incidence of sexually transmitted infections during pregnancy.Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study)
P2860
Q21144588-2687B1CD-49F8-4E45-B118-7B129619B552Q27027323-6C18D6C0-6F12-4B78-B597-36C88CD789AAQ30660068-1D1D74E0-B4FA-4D6E-8854-C4D5DF5A86C8Q30823365-7EFC66E2-A7E0-4FCA-B05D-CC999E7CB733Q31014284-4C965444-A230-42F2-98FA-6CC0E60B857FQ33552342-1C0CE957-38B4-4E1E-B81E-7DD9F5A0E6AAQ33631772-91CDFAA1-D55C-4A40-9025-E8F209E577A4Q33707284-007C4E4E-226E-43B9-A59C-6BD55286B8DCQ34173869-4E395DF2-3DC6-4450-AF45-D024998E0410Q34700364-44CAA841-F5F9-4C8E-A94E-503D64849538Q35817142-5315976D-C218-493A-A6BB-BBC889959AADQ35988763-57808DAB-DA27-4D2C-8D7A-D07B1C02A723Q36080869-0523AAAA-DE61-46B3-A621-F3F0E77D4CFFQ36220941-9F2E90AD-29B5-4333-BFBF-CAF488F7091CQ37014243-B46A7625-EA68-4206-B67B-4C0CA16964E6Q37409664-AE9CB6EB-5280-444A-A055-30A2F128B974Q37628108-19065F02-ACB7-4EB0-953E-A2A6E22E195AQ38189088-2AD19163-4865-476F-A241-4E26088A3C4BQ38358383-DB775F3C-4C3B-4477-831A-246F86216561Q38858718-0E2BBBBC-9703-4400-BA8E-27ABCD717BA2Q38930251-1D7FC638-619A-49D0-B0B0-6DDBE8579BA5Q38968366-AEFF0939-B786-4730-A3C0-E1D38D52B69CQ40515915-ECEBBD78-701C-4AFA-9FCB-8E783696F254Q47557200-85B23E43-6769-4522-8CEB-4AF6417C78ABQ52683139-9ED1F4A7-F831-485E-86D6-FF8CBB48F8A0Q55328542-382E649B-50F2-4885-A255-BCBDF55B78B9Q56954236-6F1796C3-4528-441E-9AEA-61F6C0B5B6A5
P2860
Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Oral and injectable contracept ...... g women in sub-Saharan Africa.
@en
Oral and injectable contracept ...... g women in sub-Saharan Africa.
@nl
type
label
Oral and injectable contracept ...... g women in sub-Saharan Africa.
@en
Oral and injectable contracept ...... g women in sub-Saharan Africa.
@nl
prefLabel
Oral and injectable contracept ...... g women in sub-Saharan Africa.
@en
Oral and injectable contracept ...... g women in sub-Saharan Africa.
@nl
P2093
P1433
P1476
Oral and injectable contracept ...... g women in sub-Saharan Africa.
@en
P2093
Ariane van der Straten
Elizabeth T Montgomery
Kelly Blanchard
Nancy S Padian
Sandra I McCoy
Wenjing Zheng
P304
P356
10.1097/QAD.0B013E32835DA401
P407
P50
P577
2013-03-01T00:00:00Z